EPKINLY 4 mg/.8mL
epcoritamab-bysp · INJECTION, SOLUTION · Genmab US, Inc.
No Recall History
Plain English
EPKINLY is a injection, solution containing epcoritamab-bysp at 4 mg/.8mL, taken subcutaneous. Manufactured by Genmab US, Inc..
Key Facts
- Brand Name
- EPKINLY
- Generic Name
- epcoritamab-bysp
- NDC Code (Product)
82705-002- Manufacturer
- Genmab US, Inc.
- Strength
- 4 mg/.8mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761324
- Drug Class
- Bispecific CD20-directed CD3 T Cell Engager [EPC]
- Marketing Start
- 05/19/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is EPKINLY used for?
EPKINLY contains epcoritamab-bysp. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is EPKINLY a controlled substance?
EPKINLY is not classified as a controlled substance by the DEA.
What is the generic name for EPKINLY?
The generic name for EPKINLY is epcoritamab-bysp. There are no other listed brand versions of epcoritamab-bysp.
What is the NDC code for EPKINLY 4 mg/.8mL?
The NDC (National Drug Code) for EPKINLY 4 mg/.8mL is 82705-002, listed by Genmab US, Inc..
Other EPKINLY Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)